Immediate Implant With Bone GraftNCT07027904
Immediate Implant in Posterior Mandible Region
A study testing Implant in people with Immediate Implant With Bone Graft, run by WASIM MHD JEHAD HALABI.
Trial summary
This study aims to evaluate implant stability and Width bone after placement of immediate implant and Xenograft mixed with Hyaluronic acid or with Platelet-Rich Fibrin (PRF) at posterior mandible region Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Immediate Implant With Bone Graft
- What is being tested?
- Implant
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 24 participants
- Where
- No sites listed yet
- Study dates
- 12 Jun 2025to 1 Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- • Age ≥ 18 years.
- Both sexes.
- Cooperative and likely to maintain good dental health.
- Recent extraction multi roots.
- There is a bone between (2 or 3) mm at lest from the apex of the root.
Who cannot join
- • Patients who had undergone previous extraction of all badly decayed teeth .
- Implant placement in both healed bone and at the extraction sites in the same procedure.
- Presence of any local or systemic factors that might contraindicate oral surgery.
- Poor oral hygiene.
- Conditions that complicate wound healing such as uncontrolled diabetes, smoking (10 cigarettes a day), pregnancy, a history of drug or alcohol abuse, and an inability or unwillingness to return for follow-ups after occlusal loading.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Immediate Implant Placement Using Xenograft as Space Filling Material Mixed With Platelet-Rich Fibrin (PRF) Versus Hyaluronic Acid in Posterior Mandible Region
This study aims to evaluate implant stability and Width bone after placement of immediate implant and Xenograft mixed with Hyaluronic acid or with Platelet-Rich Fibrin (PRF) at posterior mandible region
- Conditions
- Immediate Implant With Bone Graft
- Being tested
- Implant
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ImplantDevice
The immediate implant was placed, and the surrounding cavity was filled with xenograft bone material, along with the application of hyaluronic acid or platelet-rich fibrin (PRF) to enhance healing and bone integration.
| Study group | Role | What they receive |
|---|---|---|
| using xenograft as space filling material mixed with hyaluronic acid | Active comparator | the jumping space will packed using Xenograft (cur oss , Astro star) with particle size ranging from 0.25 to 1 mm and it will be mixed with hyaluronic acid Receives: Device: Implant |
| xenograft (cur oss , Astro star ) mixed with Platelet-Rich Fibrin (PRF) | Experimental | the jumping space will packed using Xenograft (cur oss , Astro star) with particle size ranging from 0.25 to 1 mm and it will be mixed with Platelet-rich fibrin (PRF) Receives: Device: Implant |
What is being measured
The primary outcome is the main question the study is designed to answer.
Implant secondary stability
Method of Measurement (Using the Osstell® Device.) -Unit of Measurement (ISQ)
Measured: 6 months
Secondary outcomes (1)
width bone
Method of Measurement (Conebeam computed tomography (CBCT) ) -Unit of Measurement (Hounsfield unit)
Measured: immediate postoperative and at 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Jun 2025
- Study start12 Jun 2025 (estimated)
- Primary completion1 Jul 2026 (estimated)
- Study completion1 Aug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Immediate Implant With Bone GraftStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 24 participants (estimated)
Sponsor and investigators
- Lead sponsor
- WASIM MHD JEHAD HALABI
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, WASIM MHD JEHAD HALABI, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07027904
- Sponsor's protocol ID
- xenograft with (PRF)
- Status last verified
- Jun 2025
- First submitted
- 19 May 2025
- Last updated
- 19 Jun 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Immediate Implant Placement Using Xenograft as Space Filling Material Mixed With Platelet-Rich Fibrin (PRF) Versus Hyaluronic Acid in Posterior Mandible Region
- ClinicalTrials.gov ID
- NCT07027904
- Acronym / sponsor ID
- xenograft with (PRF)
- Conditions
- Immediate Implant With Bone Graft
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 24 participants (estimated)
- Lead sponsor
- WASIM MHD JEHAD HALABIUniversity, hospital or other
- Study start
- 12 Jun 2025 (estimated)
- Primary completion
- 1 Jul 2026 (estimated)
- Study completion
- 1 Aug 2026 (estimated)
- First posted
- 19 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to evaluate implant stability and Width bone after placement of immediate implant and Xenograft mixed with Hyaluronic acid or with Platelet-Rich Fibrin (PRF) at posterior mandible region
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| using xenograft as space filling material mixed with hyaluronic acid | Active comparator | Device: Implantthe jumping space will packed using Xenograft (cur oss , Astro star) with particle size ranging from 0.25 to 1 mm and it will be mixed with hyaluronic acid |
| xenograft (cur oss , Astro star ) mixed with Platelet-Rich Fibrin (PRF) | Experimental | Device: Implantthe jumping space will packed using Xenograft (cur oss , Astro star) with particle size ranging from 0.25 to 1 mm and it will be mixed with Platelet-rich fibrin (PRF) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- • Age ≥ 18 years.
Key exclusion criteria (5 listed)
- • Patients who had undergone previous extraction of all badly decayed teeth .
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ImplantThe immediate implant was placed, and the surrounding cavity was filled with xenograft bone material, along with the application of hyaluronic acid or platelet-rich fibrin (PRF) to enhance healing and bone integration. | Device | using xenograft as space filling material mixed with hyaluronic acid, xenograft (cur oss , Astro star ) mixed with Platelet-Rich Fibrin (PRF) |
Primary outcome
Implant secondary stability
Time frame: 6 months
Method of Measurement (Using the Osstell® Device.) -Unit of Measurement (ISQ)
1 secondary outcome
width bone
Time frame: immediate postoperative and at 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Jun 2025.
- Individual participant dataSharing planned: No
Related trials for Immediate Implant With Bone Graft
Not yet recruiting
Hyaluronic Acid Combined With Xenograft Versus Xenograft Alone in Immediate Implant Placement
Immediate Implant Placement in the Esthetic Zone, NON-RESTORABLE TOOTH IN ESTHETIC ZONE
Not yet recruiting
Long-Term Bone Dimensional Changes Following Flapless Immediate Implant Placement
Thin Labial Plate
Recruiting
Dimensional Changes Following Immediate Implant Placement in Molar Extraction Sockets With or Without Bone Graft
Immediate Implants
Not yet recruiting
Socket Shield Technique With CGF and Xenograft for Immediate Implants
Alveolar Bone Loss, Socket Shield Technique
Not yet recruiting
Clinical and Radiographic Evaluation of CGF and Alloplastic Grafting in Participants Undergoing the Socket Shield Technique for Immediate Anterior Maxillary Implant Placement. This Study Assesses Bone Healing and Stability When Managing the Crestal Gap in the Esthetic Zone.
Alveolar Ridge Resorption, Bone Loss in the Esthetic Zone
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing Implant in people with Immediate Implant With Bone Graft, run by WASIM MHD JEHAD HALABI.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 19 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact WASIM HALABI, MSc degree candidate (+201152922450, wasim.halabi@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Implant secondary stability (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jun 2025.